News
A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power—no batteries, no ...
Treating arthritis pain and stiffness is key to living with the condition. Learn about anti-inflammatory drug treatment, side effects, and alternatives.
Zeposia has also been approved for MS and submitted for UC treatment in Europe, and BMS wants to get it to market quickly – it’s using a valuable priority review voucher to shorten the time ...
Bristol-Myers Squibb’s Zeposia (ozanimod) ... After a year’s treatment, 37% of subjects on BMS’ drug were still in remission, compared to 18.5% of those in the control arm.
Some, such as period pain, can pass with time. Others need urgent medical treatment. ... Zeposia and pregnancy, breastfeeding, and birth control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results